REVIVO BioSystems in an innovative and service-oriented company specialising in 4D human tissue models. We recreate microphysiological conditions in our organ-on-chip platform technology as close as possible to the ones in the human body so that natural tissue properties are established in our ex vivo and in vitro models. We demonstrate superior morphology and barrier properties in our 4D tissue models and the ability to mimic the function of the blood flow. This next generation technology enables new discovery and methods in mechanistic studies for quantifying and qualifying the safety, efficacy and permeation of active ingredients and product formulations.
Our team of engineers and biologists has many years of experience in biomedical engineering, cell cultures, microfluidics and tissue engineering. Aiming to become the leading Asian and global provider of enabling technologies and services for ex vivo and in vitro testing of chemicals, ingredients, cosmetic formulations and therapeutics, our goal is to deliver products and services with unmatched quality, consistency, reproducibility, convenience, and ease-of-use.
At REVIVO Biosystems, we are still feeling tremendous excitement over the recent progress we made! I want to take this opportunity to reiterate my appreciation for your interest and support. I’d also like to share some details about our Dare to Act brand philosophy. Reflecting our corporate culture, it drives our operations and expands the level of engagement and support we provide.
Dare to Act characterizes our fearless, multidisciplinary approach to research. At REVIVO Biosystems we encourage scientists and researchers to transcend the boundaries between scientific disciplines: to explore the intersection of biology and microfluidics; to expand the relationship between bioengineering and skincare. Our engineers are at their best when the challenge is greatest. Toxicologists, chemists, and pharmacologists are truly inspired as they dare to develop new, alternative, and more ethical methodologies. These innovators dare to push the boundaries, fully aware that as science advances, so too will humanity.
Dare to Act is our way of validating the trust you have placed in us. It facilitates the ongoing development of strong commercial propositions and the efficient generation of reliable support data for successful mechanistic safety and efficacy claim differentiation. Going from strength to strength, we build on our knowledge and unique expertise in 4D models to understand the mode of action of ingredients and actives. With us, you have access to the most realistic human tissue models and testing platform — models that mimic blood flow to recreate the dynamic conditions of life. Ultimately, anything is possible if you Dare to Act.
Dr. Massimo Alberti
CEO of REVIVO BioSystems